Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut‐off levels
- 3 July 2018
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (1) , 103-112
Abstract
Background and Aim Fecal immunochemical test (FIT) is used in colorectal cancer (CRC) screening, but number of tests and cut‐off level differ by program. The aim was to evaluate CRC‐screening with two FIT samples in average‐risk 60‐year‐old men and women, and to investigate Hemoglobin (Hb) level in correlation to adenoma characteristics. Methods We analyzed a cohort from SCREESCO (Screening of Swedish Colons) trial where participants with at least one of two FIT samples ≥10μgHb/g are offered colonoscopy. FIT‐levels and colonoscopy findings were assessed in multivariable analyses. Cut‐off levels 10‐80μgHb/g for one and two samples were assessed. FIT‐levels and AN were investigated by gender. Results 12383 participated and 1182 positives (551 women) completed colonoscopy diagnosing 27 (2.3%) CRC and 269 (23%) advanced adenomas (AA). Median FIT‐level was 241.0 and 23.8 for CRC and AA compared to 13.4‐15.8 in other subgroups (p=0.002) correlating with adenoma size (p=0.038). CRC was detected in 22 and 19 subjects for first sample at cut‐off 20 and 40μgHb/g, compared to 20 and 17 for mean of two samples at cut‐off 40 and 80μgHb/g (p<0.05). Men had more AN (CRC+AA),(p=0.003). In women similar number of AN would be detected with cut‐off lowered from 40 to 20μgHb/g or 80 to 40μgHb/g, requiring additional 26‐34% colonoscopies. Conclusion In average‐risk 60‐year‐olds, FIT was higher in participants with AN, and correlated with adenoma size. FIT‐screening with one sample at low cut‐off detected more CRC than two samples at higher cut‐off. Applying lower cut‐off in women to equalize gender differences in AN would result in considerable increase in colonoscopy workload.Keywords
Funding Information
- Bengt Ihres Foundation
- Cancerfonden
This publication has 29 references indexed in Scilit:
- Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopyEuropean Journal of Cancer, 2013
- Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screeningHistopathology, 2011
- Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasiaBritish Journal of Cancer, 2011
- Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting AttendanceClinical Gastroenterology and Hepatology, 2011
- High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, ItalyGut, 2010
- Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer ScreeningAmerican Journal of Gastroenterology, 2010
- Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2009
- Performance of immunochemical faecal occult blood test in colorectal cancer screening in average‐risk population according to positivity threshold and number of samplesInternational Journal of Cancer, 2009
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programmeBritish Journal of Cancer, 2007